{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:20:52Z","timestamp":1785522052782,"version":"3.56.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"DOI":"10.1186\/s41927-026-00656-6","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T17:12:48Z","timestamp":1779469968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effect of belimumab combined with conventional treatment on NK cell count in childhood systemic lupus erythematosus"],"prefix":"10.1186","volume":"10","author":[{"given":"Hongjun","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihua","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"issue":"6","key":"656_CR1","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","volume":"78","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736\u201345.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"656_CR2","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s11882-024-01169-3","volume":"24","author":"A Aggarwal","year":"2024","unstructured":"Aggarwal A, Fernandes TAP, Migowa A, et al. Childhood-Onset Systemic Lupus Erythematosus (cSLE): An International Perspective. Curr Allergy Asthma Rep. 2024;24(10):559\u201369.","journal-title":"Curr Allergy Asthma Rep"},{"key":"656_CR3","doi-asserted-by":"publisher","first-page":"108274","DOI":"10.1016\/j.clim.2019.108274","volume":"209","author":"EMD Smith","year":"2019","unstructured":"Smith EMD, Lythgoe H, Midgley A, Beresford MW, Hedrich CM. Juvenile-onset systemic lupus erythematosus: Update on clinical presentation, pathophysiology and treatment options. Clin Immunol. 2019;209:108274.","journal-title":"Clin Immunol"},{"issue":"9","key":"656_CR4","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1681\/ASN.2013010026","volume":"24","author":"M Lech","year":"2013","unstructured":"Lech M, Anders HJ. The pathogenesis of lupus nephritis. J Am Soc Nephrol. 2013;24(9):1357\u201366.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"656_CR5","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1002\/art.30613","volume":"63","author":"R Furie","year":"2011","unstructured":"Furie R, Petri M, Zamani O, et al. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum. 2011;63(12):3918\u201330.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"656_CR6","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1136\/annrheumdis-2011-200937","volume":"71","author":"RF van Vollenhoven","year":"2012","unstructured":"van Vollenhoven RF, Petri MA, Cervera R, et al. Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response. Ann Rheum Dis. 2012;71(8):1343\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"656_CR7","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1177\/096120339700600905","volume":"6","author":"FM Erkeller-Yuksel","year":"1997","unstructured":"Erkeller-Yuksel FM, Lydyard PM, Isenberg DA. Lack of NK cells in lupus patients with renal involvement. Lupus. 1997;6(9):708\u201312.","journal-title":"Lupus"},{"issue":"1","key":"656_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13075-022-02731-y","volume":"24","author":"Z Lu","year":"2022","unstructured":"Lu Z, Tian Y, Bai Z, et al. Increased oxidative stress contributes to impaired peripheral CD56dimCD57\u2009+\u2009NK cells from patients with systemic lupus erythematosus. Arthritis Res Ther. 2022;24(1):48.","journal-title":"Arthritis Res Ther"},{"key":"656_CR9","doi-asserted-by":"publisher","first-page":"622306","DOI":"10.3389\/fimmu.2021.622306","volume":"12","author":"UC Kucuksezer","year":"2021","unstructured":"Kucuksezer UC, Aktas Cetin E, Esen F, et al. The Role of Natural Killer Cells in Autoimmune Diseases. Front Immunol. 2021;12:622306.","journal-title":"Front Immunol"},{"issue":"4","key":"656_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.5114\/reum.2022.119042","volume":"60","author":"D Soelistyoningsih","year":"2022","unstructured":"Soelistyoningsih D, Susianti H, Kalim H, Handono K. The phenotype of CD3-CD56bright and CD3-CD56dim natural killer cells in systemic lupus erythematosus patients and its relation to disease activity. Reumatologia. 2022;60(4):258\u201365.","journal-title":"Reumatologia"},{"issue":"10","key":"656_CR11","doi-asserted-by":"publisher","first-page":"103648","DOI":"10.1016\/j.autrev.2024.103648","volume":"23","author":"L Arnaud","year":"2024","unstructured":"Arnaud L, Chasset F, Martin T. Immunopathogenesis of systemic lupus erythematosus: An update. Autoimmun Rev. 2024;23(10):103648.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"656_CR12","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","volume":"65","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D\u2019Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65(2):521\u201330.","journal-title":"Kidney Int"},{"issue":"4","key":"656_CR13","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","volume":"93","author":"IM Bajema","year":"2018","unstructured":"Bajema IM, Wilhelmus S, Alpers CE, et al. Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int. 2018;93(4):789\u201396.","journal-title":"Kidney Int"},{"issue":"3S2","key":"656_CR14","first-page":"S34","volume":"114","author":"GM Portalatin","year":"2022","unstructured":"Portalatin GM, Gebreselassie SK, Bobart SA. Lupus nephritis - An update on disparities affecting african americans. J Natl Med Assoc. 2022;114(3S2):S34\u201342.","journal-title":"J Natl Med Assoc"},{"issue":"42","key":"656_CR15","doi-asserted-by":"publisher","first-page":"eadz1726","DOI":"10.1126\/sciadv.adz1726","volume":"11","author":"E L\u2019Estrange-Stranieri","year":"2025","unstructured":"L\u2019Estrange-Stranieri E, Gottschalk TA, Kong AM, et al. Lyn restrains lupus via kinase-independent mechanisms that limit Toll-like receptor activation and type I interferon responsiveness. Sci Adv. 2025;11(42):eadz1726.","journal-title":"Sci Adv"},{"issue":"10","key":"656_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41584-022-00826-z","volume":"18","author":"A Psarras","year":"2022","unstructured":"Psarras A, Wittmann M, Vital EM. Emerging concepts of type I interferons in SLE pathogenesis and therapy. Nat Rev Rheumatol. 2022;18(10):575\u201390.","journal-title":"Nat Rev Rheumatol"},{"issue":"19","key":"656_CR17","doi-asserted-by":"publisher","first-page":"9365","DOI":"10.3390\/ijms26199365","volume":"26","author":"B Dzhambazov","year":"2025","unstructured":"Dzhambazov B. Special Issue: Autoimmune Diseases: A Swing Dance of Immune Cells. Int J Mol Sci. 2025;26(19):9365.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"656_CR18","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2215\/CJN.05780616","volume":"12","author":"S Almaani","year":"2017","unstructured":"Almaani S, Meara A, Rovin BH. Update on Lupus Nephritis. Clin J Am Soc Nephrol. 2017;12(5):825\u201335.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"656_CR19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.rce.2024.03.003","volume":"224","author":"A Gil-D\u00edaz","year":"2024","unstructured":"Gil-D\u00edaz A, Mart\u00edn Guerra J, Parra Caballero P, et al. Diagnosis and treatment of deep vein thrombosis of the lower and upper limbs. 2024 recommendations of the venous thromboembolism group of the Spanish Society of Internal Medicine. Rev Clin Esp (Barc). 2024;224(5):300\u201313.","journal-title":"Rev Clin Esp (Barc)"},{"key":"656_CR20","doi-asserted-by":"crossref","unstructured":"Fluder NW, Humbel M, Recazens E, et al. Mitochondrial dysfunction drives natural killer cell dysfunction in systemic lupus erythematosus. medRxiv [Preprint]; 2025.","DOI":"10.1101\/2025.01.28.25321013"},{"key":"656_CR21","doi-asserted-by":"publisher","first-page":"896228","DOI":"10.3389\/fimmu.2022.896228","volume":"13","author":"A Ram\u00edrez-Labrada","year":"2022","unstructured":"Ram\u00edrez-Labrada A, Pesini C, Santiago L, et al. All About (NK Cell-Mediated) Death in Two Acts and an Unexpected Encore: Initiation, Execution and Activation of Adaptive Immunity. Front Immunol. 2022;13:896228.","journal-title":"Front Immunol"},{"issue":"7","key":"656_CR22","doi-asserted-by":"publisher","first-page":"e70134","DOI":"10.1002\/jev2.70134","volume":"14","author":"Y Gong","year":"2025","unstructured":"Gong Y, Jin L, Duan L, et al. Extracellular Vesicles Derived From Streptococcus anginosus Aggravate Lupus Nephritis by Triggering TLR2-MyD88-NF-\u03baB Signalling in NK Cells. J Extracell Vesicles. 2025;14(7):e70134.","journal-title":"J Extracell Vesicles"},{"issue":"6","key":"656_CR23","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/art.30313","volume":"63","author":"B Hervier","year":"2011","unstructured":"Hervier B, Beziat V, Haroche J, et al. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-\u03b3 production in patients with active disease. Arthritis Rheum. 2011;63(6):1698\u2013706.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"656_CR24","first-page":"138","volume":"44","author":"J Mielle","year":"2023","unstructured":"Mielle J, Morello E, Le Texier L, et al. B cell orchestration of NK cell phenotype and function in autoimmunity. Trends Immunol. 2023;44(2):138\u201349.","journal-title":"Trends Immunol"},{"issue":"11","key":"656_CR25","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.2215\/CJN.02520322","volume":"17","author":"R Furie","year":"2022","unstructured":"Furie R, Rovin BH, Houssiau F, et al. Safety and Efficacy of Belimumab in Patients with Lupus Nephritis: Open-Label Extension of BLISS-LN Study. Clin J Am Soc Nephrol. 2022;17(11):1620\u201330.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"656_CR26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s40259-023-00597-3","volume":"37","author":"A Kale","year":"2023","unstructured":"Kale A, Lech M, Anders HJ, Gaikwad AB. Lupus Nephritis: New and Emerging Biologic and Targeted Therapies. BioDrugs. 2023;37(4):463\u201375.","journal-title":"BioDrugs"},{"issue":"6","key":"656_CR27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/jleuko\/qiad030","volume":"113","author":"D Li","year":"2023","unstructured":"Li D, Liu S, Liu R, et al. The potential role of BAFF in modulating NK cell function: implications for autoimmune diseases. J Leukoc Biol. 2023;113(6):567\u201376.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"656_CR28","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, Li J, Fu M, Zhao X, Wang W. The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther. 2021;6(1):402.","journal-title":"Signal Transduct Target Ther"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-026-00656-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00656-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00656-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:09:44Z","timestamp":1785517784000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41927-026-00656-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["656"],"URL":"https:\/\/doi.org\/10.1186\/s41927-026-00656-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8463532\/v1","asserted-by":"object"}]},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"28 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of the Children\u2019s Hospital of Soochow University (Approval number: 2025cs182). All procedures performed were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments. Informed consent was obtained from the legal guardians of all individual participants included in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"61"}}